Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Ovarian Neoplasms 2Lung Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Oligodendroglioma 1Mouth Neoplasms 1Liver Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma in Situ 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Radiotherapy 3Paclitaxel 3Taxes 2Etoposide 2Erlotinib Hydrochloride 2Docetaxel 2Cisplatin 2Carboplatin 2Bevacizumab 2vandetanib 1sargramostim 1romidepsin 1motesanib diphosphate 1advexin 1Vinorelbine 1Topotecan 1Soybean Proteins 1Radiotherapy, Conformal 1Radiation 1Pemetrexed 1Gemcitabine 1Gefitinib 1Doxorubicin 1Diathermy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Adenocarcinoma, Bronchiolo-Alveolar × advexin × Clear all
NCT00003649 2023-06-22

Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Eastern Cooperative Oncology Group

Phase 1 Completed
Thoracic

Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡